-
Summary
Join S&P Global Market Intelligence for an insightful webinar tailored for private equity and venture capital professionals, where we will explore the intricate workflow of investing in the BioPharma sector. Led by Bonanza Chalaban, Head of BioPharma Product, Kevin Zacharuk, Head of Private Equity for Data & Research, and moderated by Joe Boo, Visible Alpha Sales Manager, this session will provide a comprehensive overview of the tools and strategies necessary for evaluating investment opportunities in the rare disease market.
Agenda:
- Introduction to the Private Equity and Venture Capital Workflow in BioPharma: Gain insight into the unique considerations and methodologies employed by private equity and venture capital firms in the BioPharma space.
- Understanding Management Views: Use S&P Capital IQ Pro transcripts and filings to assess how company management teams view the opportunity within the rare disease landscape.
- In-Depth Market Research: Leverage S&P Global Aftermarket Research to conduct qualitative analyses through detailed research reports on the rare disease indication.
- Market Size, Competitive Landscape, and Revenue Forecasting: Explore Visible Alpha BioPharma to analyze current market size, revenue by indication, and forward-looking consensus estimates within the competitive landscape for competing drugs, highlighting the potential market opportunities.
This engaging session is designed to equip you with the knowledge and tools needed to make informed investment decisions in the BioPharma sector. Don't miss this opportunity to enhance your understanding of the market dynamics and investment potential within this critical industry.
Moderator
S&P Global Market Intelligence
Joe Boo
Visible Alpha Sales Manager
Joe is a Sales Manager within Visible Alpha covering Private Equity, Investment Banking, and Asset Managers. Prior to S&P Global, Joe was at Visible Alpha for 9 years as the 8th employee in various teams from Client Success to Inside Sales to Business Development. Earlier in his career, Joe spent his time on the business development side in equity research.
Joe holds a B.S. in Chemistry from Stony Brook University.
Speakers
S&P Global Market Intelligence
Bonanza Chalaban
Head of BioPharma Product
Bonanza is Head of BioPharma Product at S&P Global Market Intelligence, where he leads the firm’s BioPharma product strategy, development, and go-to-market efforts.
Prior to rejoining S&P Global, Bonanza spent eight years at Visible Alpha where he held multiple product leadership roles. Earlier in his career, Bonanza worked in strategy, M&A, and product development at S&P Global, and began his career as an equity research analyst, covering public retail companies for five years. Bonanza holds a B.A. in Economics from Yale University.
S&P Global Market Intelligence
Kevin Zacharuk
Head of Private Equity, Data & Research
Kevin Zacharuk leads the Private Equity segment within the Data & Research division at Market Intelligence and is responsible for overall Private Equity segment performance. His primary responsibilities include leading business development, sourcing and prioritization of enhancements, uncovering new products or partnerships, managing GTM efforts, and any other activity accelerating products and services offered to private markets.
Kevin began his career at S&P Global in 2014 in our New York City office. He has held a variety of roles in Product Management across multiples products since 2018 and is now based out of Toronto, Canada.
Kevin holds an HBA from the Ivey School of Business.
Questions?
Please contact us if you need more information or have trouble accessing the webinar.